1. MAYER, L., EISENHARDT, D. « Lack of induction of suppressor T-cells by intestinal epithelial cells from patients with inflammatory bowel disease » dans J Clin Invest, 1990; 86:1255-1260.
2. SAXON, A., SHANAHAN, F., LANDERS, C., GANZ, T., TARGAN, S. « A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease » dans J Allergy Clin Immuno, 1990; 86:202-210.
3. GITNICK, G. « Etiology of inflammatory bowel disease: Where have we been? Where are we going? » dans Scand J Gastroenterol, 1990; 25 (Suppl. 175):93-96.
4. DAS, K.M., VECCHI, M., SAKAMAKI, S. « A shared and unique epitope(s) on human colon, skin, and biliary epithelium detected by a mono-clonal antibody » dans Gastroenterology, 1990; 98:464-469.
5. SELDENRIJK, C.A., DREXHAGE, H.A., MEUWISSEN, S.G., MEIJER, C.J. « T-cellular immune reactions (in macrophage inhibition factor assay) against Mycobacterium paratuberculosis, Mycobacterium kansasii, Mycobacterium tuberculosis, Mycobacterium avium in patients with chronic inflammatory bowel disease » dans Gut, 1990; 31:529-535.
6. KATZ, K.D., HOLLANDER, D., VADHEIM, C.M. et coll. « Intestinal permeability in patients with Crohn's disease and their healthy relatives » dans Gastroenterology, 1989; 97:927-931.
7. MODIGLIANI, R., MARY, Y.J., SIMON, J.F. et coll. « Clinical, biological, and endoscopic picture of attacks of Crohn's disease: evolution on prednisone » dans Gastroenterology, 1990; 98:811-818.
8. International Mesalazine Study Group. « Coded oral 5-aminosalicylic acid versus placebo in maintaining remission of inactive Crohn's disease » dans Aliment Pharmacol Ther, 1990; 4:55-64.
9. PRESENT, D.H. « 6-Mercaptopurine and other immunosuppressive agents in the treatment of Crohn's disease and ulcerative colitis » dans Gastroenterol Clin North Am, 1989; 18:57-71.
10. PRESENT, D.H., MELTZER, S.J., KRUMHOLZ, M.P., WOLKE, A., KORELITZ, B.I. « 6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity » dans Ann Intern Med, 1989; 111:641-649.
11. BRYNSKOV, J., FREUND, I., RASMUSSEN, S.N. et coll. « A placebo-controlled, double-blind, randomized trial of cyclosporin therapy in active chronic Crohn's disease » dans N Engl J Med, 1989; 321:845-850.
12. FEAGAN, B.G., McDONALD, W.D. et coll. « Low-dose cyclosporine for the treatment of Crohn's disease » dans N Engl J Med, 1994; 330:1846-1851.
13. FEDORAK, R.N., EMPEY, L.R., MacARTHUR, C., JEWELL, L.D. « Misoprostol provides a colonic mucosal protective effect during acetic acid-induced colitis in rats » dans Gastroenterology, 1990; 98:615-625.
14. WALLACE, J.L., KEENAN, C.M. « An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis » dans Am J Physiol, 1990; 258:G527-534.
15. SALOMON, P., KORNBLUTH, A.A., JANOWITZ, H.D. « Treatment of ulcerative colitis with fish oil n-3-omega-fatty acid: an open trial » dans J Clin Gastroenterol, 1990; 12:157-161.
16. CAMPIERI, M., DE FRANCHIS, R., BIANCHI PORRO, G., RANZI, T., BRUNETTI, G., BARBARA, L. « Mesalazine (5-aminosalicylic acid) suppositories in the treatment of ulcerative proctitis or distal proctosigmoiditis: a randomized controlled trial » dans Scand J Gastroenterol, 1990; 25:663-668.
17. CAMPIERI, M., GIONCHETTI, P., BELLUZZI, A. et coll. « Topical treatment with 5-aminosalicylic acid in distal ulcerative colitis by using a new suppository preparation: a double-blind placebo controlled trial » dans Int J Colorectal Dis, 1990; 5:79-81.
18. RILEY, S.A., TURNBERG, L.A. « Sulphasalazine and the aminosalicylates in the treatment of inflammatory bowel disease » dans Q J Med, 1990; 75:551-562.
19. KOZAREK, R.A., PATTERSON, D.J., GELFAND, M.D., BOTOMAN, B.A., BALL, T.J., WILSKE, K.R. « Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease » dans Ann Intern Med, 1989; 110:353-356.